Following depletion, cells were stained simultaneously with Lineage Cell Detection Cocktail - Biotin ( Miltenyi Biotec) and an antibody mix containing Sca - PE, cKit - APC, CD34 - FITC, IL7Ra - PacBlue, CD16 / 32 - PeCy7 ( Progenitors) or Sca - PE, cKit - APC, CD34 - FITC, CD48 - PacBlue, CD150 - PeCy7 ( HSC ), followed by a streptavidin - PerCP secondary antibody alone.	"antibody	127	135	Gene/Protein"	"Sca	151	154	Gene/Protein"	"PE	157	159	Gene/Protein"	"cKit	161	165	Gene/Protein"	"APC	168	171	Gene/Protein"	"CD34	173	177	Gene/Protein"	"IL7Ra	186	191	Gene/Protein"	"CD16	203	207	Gene/Protein"	"Sca	239	242	Gene/Protein"	"PE	245	247	Gene/Protein"	"cKit	249	253	Gene/Protein"	"APC	256	259	Gene/Protein"	"CD34	261	265	Gene/Protein"	"CD48	274	278	Gene/Protein"	"CD150	290	295	Gene/Protein"	"streptavidin	327	339	Gene/Protein"	"antibody	358	366	Gene/Protein"	"[{""token"": ""antibody"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Sca"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 157, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""cKit"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""IL7Ra"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""Sca"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 245, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""cKit"", ""start_span"": 249, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""CD48"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 290, ""end_span"": 295, ""type"": ""Gene/Protein""}, {""token"": ""streptavidin"", ""start_span"": 327, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 358, ""end_span"": 366, ""type"": ""Gene/Protein""}]"
The predictor variables of interest in this study were; age, sex, stroke type ( ischemic or hemorrhagic ), Oxfordshire Community Stroke Project ( OCSP) classification, prestroke mRS score, previous fall, fracture, stroke or transient ischemic attack ( TIA ), congestive heart failure, coronary heart disease or myocardial infarction, atrial fibrillation, diabetes, hypertension, peripheral vascular disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, hyperlipidemia, and cancer.	"stroke	66	72	Disease/Disorder"	"Stroke	129	135	Disease/Disorder"	"stroke	171	177	Disease/Disorder"	"transient ischemic attack	224	249	Disease/Disorder"	"TIA	252	255	Disease/Disorder"	"congestive heart failure	259	283	Disease/Disorder"	"coronary heart disease	285	307	Disease/Disorder"	"myocardial infarction	311	332	Disease/Disorder"	"atrial fibrillation	334	353	Disease/Disorder"	"diabetes	355	363	Disease/Disorder"	"hypertension	365	377	Disease/Disorder"	"peripheral vascular disease	379	406	Disease/Disorder"	"chronic kidney disease	408	430	Disease/Disorder"	"chronic obstructive pulmonary disease	432	469	Disease/Disorder"	"dementia	471	479	Disease/Disorder"	"hyperlipidemia	481	495	Disease/Disorder"	"cancer	501	507	Disease/Disorder"	"[{""token"": ""stroke"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""Stroke"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Disease/Disorder""}, {""token"": ""transient ischemic attack"", ""start_span"": 224, ""end_span"": 249, ""type"": ""Disease/Disorder""}, {""token"": ""TIA"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Disease/Disorder""}, {""token"": ""congestive heart failure"", ""start_span"": 259, ""end_span"": 283, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 285, ""end_span"": 307, ""type"": ""Disease/Disorder""}, {""token"": ""myocardial infarction"", ""start_span"": 311, ""end_span"": 332, ""type"": ""Disease/Disorder""}, {""token"": ""atrial fibrillation"", ""start_span"": 334, ""end_span"": 353, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 355, ""end_span"": 363, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 365, ""end_span"": 377, ""type"": ""Disease/Disorder""}, {""token"": ""peripheral vascular disease"", ""start_span"": 379, ""end_span"": 406, ""type"": ""Disease/Disorder""}, {""token"": ""chronic kidney disease"", ""start_span"": 408, ""end_span"": 430, ""type"": ""Disease/Disorder""}, {""token"": ""chronic obstructive pulmonary disease"", ""start_span"": 432, ""end_span"": 469, ""type"": ""Disease/Disorder""}, {""token"": ""dementia"", ""start_span"": 471, ""end_span"": 479, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 481, ""end_span"": 495, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 501, ""end_span"": 507, ""type"": ""Disease/Disorder""}]"
Taken together, our data demonstrate that lncRNA uc. 134 plays a key role in suppressing the proliferation, invasion, and metastasis of HCC by blocking CUL4A nuclear export to ubiquitinate LATS1 and increasing YAPS127 phosphorylation, which implicates the lncRNA uc. 134 - CUL4A - Hippo axis as a potential therapeutic target for the treatment of HCC. Fig. 5LncRNA uc. 134 represses HCC proliferation and metastasis via the uc. 134 - CUL4A - Hippo axis. a Western blot showing that CUL4A abrogated the uc. 134 - mediated activation of Hippo kinase signaling ( left ), whereas the knockdown of CUL4A reversed the si - uc. 134 - mediated repression of LATS1 and inactivation of YAP ( right ). b A Transwell analysis showed that CUL4A overexpression abrogated the uc. 134 - mediated repression of HCC cell invasion ( upper ), whereas CUL4A knockdown yielded the opposite results ( lower ).	"HCC	136	139	Disease/Disorder"	"CUL4A	152	157	Gene/Protein"	"LATS1	189	194	Gene/Protein"	"CUL4A	273	278	Gene/Protein"	"Hippo	281	286	Gene/Protein"	"HCC	347	350	Disease/Disorder"	"HCC	383	386	Disease/Disorder"	"CUL4A	434	439	Gene/Protein"	"Hippo	442	447	Gene/Protein"	"CUL4A	482	487	Gene/Protein"	"Hippo kinase	535	547	Gene/Protein"	"CUL4A	593	598	Gene/Protein"	"LATS1	650	655	Gene/Protein"	"YAP	676	679	Gene/Protein"	"CUL4A	726	731	Gene/Protein"	"HCC	794	797	Disease/Disorder"	"CUL4A	831	836	Gene/Protein"	"[{""token"": ""HCC"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Disease/Disorder""}, {""token"": ""CUL4A"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""Hippo"", ""start_span"": 281, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 347, ""end_span"": 350, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 383, ""end_span"": 386, ""type"": ""Disease/Disorder""}, {""token"": ""CUL4A"", ""start_span"": 434, ""end_span"": 439, ""type"": ""Gene/Protein""}, {""token"": ""Hippo"", ""start_span"": 442, ""end_span"": 447, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 482, ""end_span"": 487, ""type"": ""Gene/Protein""}, {""token"": ""Hippo kinase"", ""start_span"": 535, ""end_span"": 547, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 593, ""end_span"": 598, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 650, ""end_span"": 655, ""type"": ""Gene/Protein""}, {""token"": ""YAP"", ""start_span"": 676, ""end_span"": 679, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 726, ""end_span"": 731, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 794, ""end_span"": 797, ""type"": ""Disease/Disorder""}, {""token"": ""CUL4A"", ""start_span"": 831, ""end_span"": 836, ""type"": ""Gene/Protein""}]"
Since BMAL1 and CLOCK activate not only Rev - erbα but also Pparα ( Canaple et al ., 2006 ), the expected repression of the Fgf21 :: luc reporter is probably compensated by the activating potential of PPARα ( Inagaki et al ., 2007 ). Fig. 2. Regulation of the Fgf21 promoter by clock components. ( A) Dose - dependent activation of the Per1 :: luc promoter by BMAL1 and CLOCK ( black bars) and no BMAL1 / CLOCK activation of the Fgf21 :: luc reporter ( white bars) in NIH3T3 cells ( n = 3 ).	"BMAL1	6	11	Gene/Protein"	"CLOCK	16	21	Gene/Protein"	"Rev - erbα	40	50	Gene/Protein"	"Pparα	60	65	Gene/Protein"	"Fgf21	124	129	Gene/Protein"	"luc	133	136	Gene/Protein"	"PPARα	201	206	Gene/Protein"	"Fgf21	260	265	Gene/Protein"	"clock	278	283	Gene/Protein"	"Per1	336	340	Gene/Protein"	"luc	344	347	Gene/Protein"	"BMAL1	360	365	Gene/Protein"	"CLOCK	370	375	Gene/Protein"	"BMAL1	397	402	Gene/Protein"	"CLOCK	405	410	Gene/Protein"	"Fgf21	429	434	Gene/Protein"	"luc	438	441	Gene/Protein"	"[{""token"": ""BMAL1"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CLOCK"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""Ppar\u03b1"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""clock"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""Per1"", ""start_span"": 336, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 344, ""end_span"": 347, ""type"": ""Gene/Protein""}, {""token"": ""BMAL1"", ""start_span"": 360, ""end_span"": 365, ""type"": ""Gene/Protein""}, {""token"": ""CLOCK"", ""start_span"": 370, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""BMAL1"", ""start_span"": 397, ""end_span"": 402, ""type"": ""Gene/Protein""}, {""token"": ""CLOCK"", ""start_span"": 405, ""end_span"": 410, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 429, ""end_span"": 434, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 438, ""end_span"": 441, ""type"": ""Gene/Protein""}]"
The following primary antibodies were used for IHC / ICC15: rabbit anti - Ki67 ( 1: 5, 000; Abcam ); rabbit anti - activated caspase - 3 ( 1: 200; R & D Systems ); rabbit anti - CD31 ( Santa Cruz Biotechnology ); mouse anti - skeletal myosin ( 1: 400; Sigma ); rabbit anti - β1 ( 1: 200; Abgent ); mouse anti - fyn ( 1: 100; BioLegend ); mouse anti - CD44 ( 1: 100; AbD Serotec ); rabbit anti - E - cadherin ( 1: 200; Cell Signaling Technology ); mouse anti - human nuclear antigen ( HNA; 1: 100; Millipore ).	"rabbit	60	66	Organism/Species"	"Ki67	74	78	Gene/Protein"	"rabbit	101	107	Organism/Species"	"caspase - 3	125	136	Gene/Protein"	"rabbit	164	170	Organism/Species"	"CD31	178	182	Gene/Protein"	"mouse	213	218	Organism/Species"	"skeletal myosin	226	241	Gene/Protein"	"rabbit	261	267	Organism/Species"	"mouse	298	303	Organism/Species"	"fyn	311	314	Gene/Protein"	"mouse	338	343	Organism/Species"	"CD44	351	355	Gene/Protein"	"rabbit	381	387	Organism/Species"	"E - cadherin	395	407	Gene/Protein"	"mouse	447	452	Organism/Species"	"human	460	465	Organism/Species"	"[{""token"": ""rabbit"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""Ki67"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""caspase - 3"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""CD31"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Organism/Species""}, {""token"": ""skeletal myosin"", ""start_span"": 226, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 298, ""end_span"": 303, ""type"": ""Organism/Species""}, {""token"": ""fyn"", ""start_span"": 311, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 338, ""end_span"": 343, ""type"": ""Organism/Species""}, {""token"": ""CD44"", ""start_span"": 351, ""end_span"": 355, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 381, ""end_span"": 387, ""type"": ""Organism/Species""}, {""token"": ""E - cadherin"", ""start_span"": 395, ""end_span"": 407, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 447, ""end_span"": 452, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 460, ""end_span"": 465, ""type"": ""Organism/Species""}]"
The sICAM graph and data exclude two subjects who were deemed outliers with values more than three box lengths away from the 75th or 25th percentile. Table 4. Concentrations of measured inflammatory markers at each time point ( Mean values and standard deviations) Time point0 h1 h3 h6 hMean sd Mean sd Mean sd Mean sd Time × treatment: PIL - 10 ( pg / ml) PO meal0 · 561 · 350 · 541 · 340 · 541 · 200 · 511 · 300 · 03 PO + MFGM meal0 · 491 · 150 · 521 · 160 · 521 · 090 · 571 · 10IL - 6 ( pg / ml) PO meal0 · 741 · 070 · 59 * 0 · 860 · 61 * 1 · 080 · 76 †‡ 1 · 140 · 48 PO + MFGM meal0 · 721 · 350 · 591 · 230 · 540 · 950 · 761 · 36IL - 8 ( pg / ml) PO11 · 243 · 0610 · 51 * 3 · 309 · 63 * 3 · 1110 · 962 · 910 · 04 PO + MFGM11 · 113 · 2811 · 323 · 2310 · 722 · 6610 · 83 · 30TNFα ( pg / ml) PO meal2 · 490 · 702 · 360 · 562 · 290 · 622 · 360 · 640 · 13 PO + MFGM meal2 · 340 · 662 · 360 · 642 · 270 · 612 · 220 · 66IL - 18 ( pg / ml) PO meal145 · 4891 · 64148 · 4475 · 95162 · 38109 · 73150 · 9573 · 050 · 59 PO + MFGM meal154 · 2583 · 16152 · 1973 · 41155 · 3878 · 06160 · 0372 · 09MCP - 1 ( pg / ml) PO meal345 · 7593 · 66343 · 23104 · 24336 · 7294 · 82330 · 8182 · 090 · 26 PO + MFGM meal352 · 1684 · 36358 · 6190 · 41320 · 46102 · 57335 · 0597 · 92CRP ( mg / l) PO meal4 · 424 · 694 · 394 · 234 · 424 · 434 · 64 † 4 · 640 · 8 PO + MFGM meal4 · 374 · 295 · 165 · 565 · 115 · 545 · 205 · 38SAA ( mg / l) PO meal3 · 933 · 484 · 043 · 583 · 81 † 3 · 224 · 12 ‡ 3 · 710 · 91 PO + MFGM meal11 · 8530 · 7912 · 7632 · 7612 · 2031 · 6812 · 8233 · 37sICAM - 1 ( mg / l) PO meal0 · 970 · 501 · 06 * 0 · 531 · 00 † 0 · 501 · 04 *‡ 0 · 530 · 02 PO + MFGM meal0 · 960 · 510 · 970 · 500 · 950 · 500 · 970 · 51sVCAM - 1 ( mg / l) PO meal1 · 550 · 851 · 65 * 0 · 861 · 58 † 0 · 861 · 62 ‡ 0 · 860 · 13 PO + MFGM meal1 · 490 · 831 · 510 · 841 · 460 · 821 · 520 · 85Cortisol ( μg / l) PO meal1139751820859967108659595703305 *† 457081653937 *†‡ 5773520 · 76 PO + MFGM meal1083979698219933085619060780686476281613297366507PO, palm oil; PO + MFGM, palm oil + milk fat globule membrane; MCP - 1, monocyte chemoattractant protein - 1; CRP, C - reactive protein; SAA, serum amyloid A; sICAM, soluble intracellular adhesion molecule; sVCAM, soluble vascular adhesion molecule .* Significantly different from 0 h when both treatments analysed together ( P < 0 · 05 ).† Significantly different from 1 h when both treatments analysed together ( P < 0 · 05 ).‡ Significantly different from 3 h when both treatments analysed together ( P < 0 · 05 ).	"sICAM	4	9	Gene/Protein"	"- 10	341	345	Gene/Protein"	"- 6	484	487	Gene/Protein"	"- 8	636	639	Gene/Protein"	"- 18	920	924	Gene/Protein"	"- 1	1089	1092	Gene/Protein"	"- 1	1552	1555	Gene/Protein"	"- 1	1706	1709	Gene/Protein"	"MCP - 1	2070	2077	Gene/Protein"	"CRP	2117	2120	Gene/Protein"	"C - reactive protein	2122	2142	Gene/Protein"	"SAA	2144	2147	Gene/Protein"	"serum amyloid A	2149	2164	Gene/Protein"	"sICAM	2166	2171	Gene/Protein"	"intracellular adhesion molecule	2181	2212	Gene/Protein"	"sVCAM	2214	2219	Gene/Protein"	"vascular adhesion molecule	2229	2255	Gene/Protein"	"[{""token"": ""sICAM"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""- 10"", ""start_span"": 341, ""end_span"": 345, ""type"": ""Gene/Protein""}, {""token"": ""- 6"", ""start_span"": 484, ""end_span"": 487, ""type"": ""Gene/Protein""}, {""token"": ""- 8"", ""start_span"": 636, ""end_span"": 639, ""type"": ""Gene/Protein""}, {""token"": ""- 18"", ""start_span"": 920, ""end_span"": 924, ""type"": ""Gene/Protein""}, {""token"": ""- 1"", ""start_span"": 1089, ""end_span"": 1092, ""type"": ""Gene/Protein""}, {""token"": ""- 1"", ""start_span"": 1552, ""end_span"": 1555, ""type"": ""Gene/Protein""}, {""token"": ""- 1"", ""start_span"": 1706, ""end_span"": 1709, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 2070, ""end_span"": 2077, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 2117, ""end_span"": 2120, ""type"": ""Gene/Protein""}, {""token"": ""C - reactive protein"", ""start_span"": 2122, ""end_span"": 2142, ""type"": ""Gene/Protein""}, {""token"": ""SAA"", ""start_span"": 2144, ""end_span"": 2147, ""type"": ""Gene/Protein""}, {""token"": ""serum amyloid A"", ""start_span"": 2149, ""end_span"": 2164, ""type"": ""Gene/Protein""}, {""token"": ""sICAM"", ""start_span"": 2166, ""end_span"": 2171, ""type"": ""Gene/Protein""}, {""token"": ""intracellular adhesion molecule"", ""start_span"": 2181, ""end_span"": 2212, ""type"": ""Gene/Protein""}, {""token"": ""sVCAM"", ""start_span"": 2214, ""end_span"": 2219, ""type"": ""Gene/Protein""}, {""token"": ""vascular adhesion molecule"", ""start_span"": 2229, ""end_span"": 2255, ""type"": ""Gene/Protein""}]"
To begin addressing this question, we quantified TH1 cytokines ( IL - 12, IFN - γ and TNF - α ), TH2 cytokines ( IL - 4, IL - 10 and IL - 13 ), the TH17 representative cytokine IL - 17, and other inflammatory cytokines / chemokines ( IL - 1β, IL - 6, and RANTES or CCL5) in tear fluids and serum samples of keratoconus patients and control subjects.	"cytokines	53	62	Gene/Protein"	"IL - 12	65	72	Gene/Protein"	"IFN - γ	74	81	Gene/Protein"	"TNF - α	86	93	Gene/Protein"	"cytokines	101	110	Gene/Protein"	"IL - 4	113	119	Gene/Protein"	"IL - 10	121	128	Gene/Protein"	"IL - 13	133	140	Gene/Protein"	"cytokine	168	176	Gene/Protein"	"IL - 17	177	184	Gene/Protein"	"cytokines	209	218	Gene/Protein"	"chemokines	221	231	Gene/Protein"	"IL - 1β	234	241	Gene/Protein"	"IL - 6	243	249	Gene/Protein"	"RANTES	255	261	Gene/Protein"	"CCL5	265	269	Gene/Protein"	"keratoconus	307	318	Disease/Disorder"	"[{""token"": ""cytokines"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 221, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 234, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 255, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""CCL5"", ""start_span"": 265, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 307, ""end_span"": 318, ""type"": ""Disease/Disorder""}]"
A study reported increases in IL - 1β, IL - 2, IL - 5, IL - 6, IL - 12, IL - 13, in seasonal allergic conjunctivitis ( SAC ), vernal keratoconjunctivitis ( VKC) and atopic keratoconjunctivitis ( AKC ), while IL - 4, IFN - γ and IL - 10 levels were increased in SAC and VKC compared to controls [ 16 ].	"IL - 1β	30	37	Gene/Protein"	"IL - 2	39	45	Gene/Protein"	"IL - 5	47	53	Gene/Protein"	"IL - 6	55	61	Gene/Protein"	"IL - 12	63	70	Gene/Protein"	"IL - 13	72	79	Gene/Protein"	"allergic conjunctivitis	93	116	Disease/Disorder"	"SAC	119	122	Disease/Disorder"	"vernal keratoconjunctivitis	126	153	Disease/Disorder"	"VKC	156	159	Disease/Disorder"	"atopic keratoconjunctivitis	165	192	Disease/Disorder"	"AKC	195	198	Disease/Disorder"	"IL - 4	208	214	Gene/Protein"	"IFN - γ	216	223	Gene/Protein"	"IL - 10	228	235	Gene/Protein"	"SAC	261	264	Disease/Disorder"	"VKC	269	272	Disease/Disorder"	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""allergic conjunctivitis"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Disease/Disorder""}, {""token"": ""SAC"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""vernal keratoconjunctivitis"", ""start_span"": 126, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""VKC"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Disease/Disorder""}, {""token"": ""atopic keratoconjunctivitis"", ""start_span"": 165, ""end_span"": 192, ""type"": ""Disease/Disorder""}, {""token"": ""AKC"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 4"", ""start_span"": 208, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 216, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""SAC"", ""start_span"": 261, ""end_span"": 264, ""type"": ""Disease/Disorder""}, {""token"": ""VKC"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Disease/Disorder""}]"
Selective IgG anti - HIV adherence to erythrocytes. Pattern of immunoglobulin G anti - HIV ( IgG anti - HIV) determined by western blot in plasma of patients ( IgG anti - HIV - P ), plasma diluted at the same concentration than 100x concentrated IgG present in purified erythrocytes ( IgG anti - HIV - Pd ), purified erythrocytes ( IgG anti - HIV - E ), and IgG anti - HIV - E 100x concentrated ( IgG anti - HIV - Ec ).	"IgG	10	13	Gene/Protein"	"HIV	21	24	Organism/Species"	"immunoglobulin G	63	79	Gene/Protein"	"HIV	87	90	Organism/Species"	"IgG	93	96	Gene/Protein"	"HIV	104	107	Organism/Species"	"IgG	160	163	Gene/Protein"	"HIV	171	174	Organism/Species"	"IgG	246	249	Gene/Protein"	"IgG	285	288	Gene/Protein"	"HIV	296	299	Organism/Species"	"IgG	332	335	Gene/Protein"	"HIV	343	346	Organism/Species"	"IgG	358	361	Gene/Protein"	"HIV	369	372	Organism/Species"	"IgG	397	400	Gene/Protein"	"HIV	408	411	Organism/Species"	"[{""token"": ""IgG"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""immunoglobulin G"", ""start_span"": 63, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 285, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 332, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 343, ""end_span"": 346, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 358, ""end_span"": 361, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 369, ""end_span"": 372, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 397, ""end_span"": 400, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 408, ""end_span"": 411, ""type"": ""Organism/Species""}]"
In vitro modulation of β - catenin altered uc. 158 − expression in human malignant hepatocytes. uc. 158 − expression was increased in CTNNB1 - mutated human HCCs compared with non - mutated human HCCs, and in human HCC with nuclear localisation of β - catenin. uc. 158 − was increased in TAA rat CCA and reduced after treatment with Wnt / β - catenin inhibitors. uc. 158 − expression was negative in human normal liver and biliary epithelia, while it was increased in human CCA in two different cohorts.	"β - catenin	23	34	Gene/Protein"	"human	67	72	Organism/Species"	"CTNNB1	134	140	Gene/Protein"	"human	151	156	Organism/Species"	"HCCs	157	161	Disease/Disorder"	"human	190	195	Organism/Species"	"HCCs	196	200	Disease/Disorder"	"human	209	214	Organism/Species"	"HCC	215	218	Disease/Disorder"	"β - catenin	248	259	Gene/Protein"	"rat	292	295	Organism/Species"	"CCA	296	299	Disease/Disorder"	"Wnt	333	336	Gene/Protein"	"β - catenin	339	350	Gene/Protein"	"human	400	405	Organism/Species"	"human	468	473	Organism/Species"	"CCA	474	477	Disease/Disorder"	"[{""token"": ""\u03b2 - catenin"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""CTNNB1"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""HCCs"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""HCCs"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""HCC"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 248, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""rat"", ""start_span"": 292, ""end_span"": 295, ""type"": ""Organism/Species""}, {""token"": ""CCA"", ""start_span"": 296, ""end_span"": 299, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt"", ""start_span"": 333, ""end_span"": 336, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 339, ""end_span"": 350, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 400, ""end_span"": 405, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 468, ""end_span"": 473, ""type"": ""Organism/Species""}, {""token"": ""CCA"", ""start_span"": 474, ""end_span"": 477, ""type"": ""Disease/Disorder""}]"
